CA2877470C - Carbohydrate detection - Google Patents
Carbohydrate detection Download PDFInfo
- Publication number
- CA2877470C CA2877470C CA2877470A CA2877470A CA2877470C CA 2877470 C CA2877470 C CA 2877470C CA 2877470 A CA2877470 A CA 2877470A CA 2877470 A CA2877470 A CA 2877470A CA 2877470 C CA2877470 C CA 2877470C
- Authority
- CA
- Canada
- Prior art keywords
- phta
- carbohydrate
- carbohydrates
- signal
- luminescent conjugated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 241
- 238000001514 detection method Methods 0.000 title claims abstract description 63
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 240
- 238000000034 method Methods 0.000 claims abstract description 53
- 238000011002 quantification Methods 0.000 claims abstract description 16
- 238000011065 in-situ storage Methods 0.000 claims abstract description 8
- 239000001913 cellulose Substances 0.000 claims description 62
- 229920002678 cellulose Polymers 0.000 claims description 62
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 16
- 229960002897 heparin Drugs 0.000 claims description 16
- 229920002101 Chitin Polymers 0.000 claims description 15
- 229920002527 Glycogen Polymers 0.000 claims description 15
- 229940096919 glycogen Drugs 0.000 claims description 15
- 229920000856 Amylose Polymers 0.000 claims description 14
- 229920001503 Glucan Polymers 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 229920000669 heparin Polymers 0.000 claims description 13
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 11
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 11
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- -1 monoaccharides Substances 0.000 claims description 10
- 230000003287 optical effect Effects 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 8
- 238000001727 in vivo Methods 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 5
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 239000002858 neurotransmitter agent Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229910010272 inorganic material Inorganic materials 0.000 claims description 2
- 239000011147 inorganic material Substances 0.000 claims description 2
- 239000011368 organic material Substances 0.000 claims description 2
- 239000013067 intermediate product Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 description 120
- 230000008859 change Effects 0.000 description 80
- 235000010980 cellulose Nutrition 0.000 description 61
- 230000005284 excitation Effects 0.000 description 51
- 238000004458 analytical method Methods 0.000 description 26
- 230000007423 decrease Effects 0.000 description 25
- 238000010790 dilution Methods 0.000 description 21
- 239000012895 dilution Substances 0.000 description 21
- 238000000695 excitation spectrum Methods 0.000 description 21
- 238000010219 correlation analysis Methods 0.000 description 19
- 238000003556 assay Methods 0.000 description 17
- 230000003595 spectral effect Effects 0.000 description 15
- 239000000725 suspension Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 14
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 13
- 238000000295 emission spectrum Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 12
- 235000010413 sodium alginate Nutrition 0.000 description 12
- 239000000661 sodium alginate Substances 0.000 description 12
- 229940005550 sodium alginate Drugs 0.000 description 12
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 11
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 11
- 230000032770 biofilm formation Effects 0.000 description 11
- 239000000306 component Substances 0.000 description 11
- 210000002744 extracellular matrix Anatomy 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000010183 spectrum analysis Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 150000002431 hydrogen Chemical class 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000008358 core component Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- SMJRBWINMFUUDS-UHFFFAOYSA-N 2-thienylacetic acid Chemical compound OC(=O)CC1=CC=CS1 SMJRBWINMFUUDS-UHFFFAOYSA-N 0.000 description 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 229930192474 thiophene Natural products 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 101150085091 lat-2 gene Proteins 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 150000002772 monosaccharides Chemical class 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 150000003577 thiophenes Chemical class 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920002971 Heparan sulfate Polymers 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001506 fluorescence spectroscopy Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000011194 good manufacturing practice Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 2
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000003216 Oxystearin Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000013409 condiments Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000005574 cross-species transmission Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000012921 fluorescence analysis Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002135 phase contrast microscopy Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 230000004845 protein aggregation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical class CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- VMJOFTHFJMLIKL-UHFFFAOYSA-N 2-thiophen-2-ylethanol Chemical compound OCCC1=CC=CS1 VMJOFTHFJMLIKL-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000002970 Calcium lactobionate Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000950314 Figura Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 101100316117 Rattus norvegicus Unc50 gene Proteins 0.000 description 1
- 229940127321 Structural Macromolecules Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ZHXRHTSXFGTQLL-XRIGFGBMSA-N acetic acid;(2s)-2,6-diaminohexanoic acid;thiophene Chemical compound CC(O)=O.C=1C=CSC=1.NCCCC[C@H](N)C(O)=O ZHXRHTSXFGTQLL-XRIGFGBMSA-N 0.000 description 1
- ACVPKUOJYOGVBN-QTNFYWBSSA-N acetic acid;(2s)-2-aminopentanedioic acid;thiophene Chemical compound CC(O)=O.C=1C=CSC=1.OC(=O)[C@@H](N)CCC(O)=O ACVPKUOJYOGVBN-QTNFYWBSSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 101150023487 easE gene Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1250751-3 | 2012-07-02 | ||
| SE1250751A SE536793C2 (sv) | 2012-07-02 | 2012-07-02 | Detektion av kolhydrater |
| PCT/SE2013/050810 WO2014007730A1 (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2877470A1 CA2877470A1 (en) | 2014-01-09 |
| CA2877470C true CA2877470C (en) | 2022-07-19 |
Family
ID=49882344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2877470A Active CA2877470C (en) | 2012-07-02 | 2013-06-27 | Carbohydrate detection |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9958439B2 (enExample) |
| EP (1) | EP2867673B1 (enExample) |
| JP (1) | JP6317342B2 (enExample) |
| AU (1) | AU2013285614B2 (enExample) |
| BR (1) | BR112014032974B1 (enExample) |
| CA (1) | CA2877470C (enExample) |
| IN (1) | IN2014DN10649A (enExample) |
| NO (1) | NO2867673T3 (enExample) |
| PL (1) | PL2867673T3 (enExample) |
| SE (1) | SE536793C2 (enExample) |
| WO (1) | WO2014007730A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016331156B2 (en) * | 2015-10-01 | 2022-03-03 | Richter Life Science Development Ab | Detection of microbial peptides |
| FR3050271B1 (fr) | 2016-04-18 | 2018-04-13 | Centre National De La Recherche Scientifique | Procede de sequencage d'oligosaccharides |
| DE102016113166B4 (de) * | 2016-07-18 | 2022-02-24 | Joanneum Research Forschungsgesellschaft Mbh | Verfahren zum Nachweis eines Biofilms und Mittel zum Nachweis eines Biofilms |
| SE543571C2 (en) * | 2019-02-07 | 2021-03-30 | Christian Strietzel | Conducting redox oligomers |
| JP2020165847A (ja) * | 2019-03-29 | 2020-10-08 | 株式会社島津製作所 | 食品の品質判定方法、及び、食品品質判定装置 |
| US20230151405A1 (en) * | 2020-04-15 | 2023-05-18 | The Penn State Research Foundation | Biodegradable dna-alginate conjugate for reversible protein and cell labeling and imaging |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1692299B1 (en) | 2003-10-31 | 2009-07-29 | Immunetics, Inc. | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets |
| WO2007075595A2 (en) | 2005-12-20 | 2007-07-05 | Vertex Pharmacueticals Incorporated | Biofilm assay |
| ES2551744T3 (es) | 2008-10-17 | 2015-11-23 | Neuroscios Gmbh | Nuevos compuestos de tiofeno para uso en terapia |
| CN102770428B (zh) * | 2010-02-16 | 2015-07-29 | 赛拉米诺瓦公司 | 作为分子探针的寡聚噻吩衍生物 |
| GB201020236D0 (en) * | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
-
2012
- 2012-07-02 SE SE1250751A patent/SE536793C2/sv not_active IP Right Cessation
-
2013
- 2013-06-27 CA CA2877470A patent/CA2877470C/en active Active
- 2013-06-27 BR BR112014032974-5A patent/BR112014032974B1/pt active IP Right Grant
- 2013-06-27 WO PCT/SE2013/050810 patent/WO2014007730A1/en not_active Ceased
- 2013-06-27 JP JP2015520123A patent/JP6317342B2/ja active Active
- 2013-06-27 PL PL13813945T patent/PL2867673T3/pl unknown
- 2013-06-27 IN IN10649DEN2014 patent/IN2014DN10649A/en unknown
- 2013-06-27 US US14/408,440 patent/US9958439B2/en active Active
- 2013-06-27 AU AU2013285614A patent/AU2013285614B2/en active Active
- 2013-06-27 EP EP13813945.6A patent/EP2867673B1/en active Active
- 2013-06-27 NO NO13813945A patent/NO2867673T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2867673B1 (en) | 2017-12-06 |
| PL2867673T3 (pl) | 2018-07-31 |
| JP6317342B2 (ja) | 2018-04-25 |
| BR112014032974B1 (pt) | 2021-09-14 |
| AU2013285614B2 (en) | 2018-10-18 |
| BR112014032974A2 (pt) | 2017-06-27 |
| SE1250751A1 (sv) | 2014-01-03 |
| AU2013285614A1 (en) | 2015-01-22 |
| JP2015524552A (ja) | 2015-08-24 |
| EP2867673A1 (en) | 2015-05-06 |
| SE536793C2 (sv) | 2014-08-19 |
| CA2877470A1 (en) | 2014-01-09 |
| IN2014DN10649A (enExample) | 2015-09-11 |
| US9958439B2 (en) | 2018-05-01 |
| US20150212076A1 (en) | 2015-07-30 |
| EP2867673A4 (en) | 2016-03-02 |
| WO2014007730A1 (en) | 2014-01-09 |
| NO2867673T3 (enExample) | 2018-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2877470C (en) | Carbohydrate detection | |
| Ivleva et al. | Towards a nondestructive chemical characterization of biofilm matrix by Raman microscopy | |
| Wu et al. | A novel colorimetric aptasensor for detection of chloramphenicol based on lanthanum ion–assisted gold nanoparticle aggregation and smartphone imaging | |
| Sang et al. | Aminophenylboronic-acid-conjugated polyacrylic acid–Mn-doped ZnS quantum dot for highly sensitive discrimination of glycoproteins | |
| Si et al. | Rapid and accurate detection of Escherichia coli growth by fluorescent pH-sensitive organic nanoparticles for high-throughput screening applications | |
| Neu et al. | Advanced techniques for in situ analysis of the biofilm matrix (structure, composition, dynamics) by means of laser scanning microscopy | |
| Discart et al. | Critical evaluation of the determination methods for transparent exopolymer particles, agents of membrane fouling | |
| Meng et al. | Novel chitosan-based fluorescent materials for the selective detection and adsorption of Fe3+ in water and consequent bio-imaging applications | |
| Xi et al. | A selective turn-on fluorescent sensor for Cu (II) and its application in imaging in living cells | |
| US10101277B2 (en) | Poly(methyl methacrylate)-supported polydiacetylene films as colorimetric and/or fluorescent detectors | |
| Park et al. | Investigating the influence of organic matter composition on biofilm volumes in reverse osmosis using optical coherence tomography | |
| Su et al. | Novel research on okadaic acid field-based detection using cell viability biosensor and Bionic e-Eye | |
| Siri et al. | Curli amyloid fibers in Escherichia coli biofilms: the influence of water availability on their structure and functional properties | |
| Richter-Dahlfors et al. | Fluorescent optotracers for bacterial and biofilm detection and diagnostics | |
| Shim et al. | Amphiphilic Conjugated Polythiophene‐based Fluorescence “Turn on” Sensor for Selective Detection of Escherichia coli in Water and Milk | |
| Ballance et al. | Interactions of polysaccharides extracted by mild acid hydrolysis from the leaves of Sphagnum papillosum with either phenylhydrazine, o-phenylenediamine and its oxidation products or collagen | |
| CN104807865A (zh) | 应用于肌红蛋白检测的电化学适配体传感器的制备方法 | |
| de Pablo et al. | Label-free live microalgal starch screening via Raman flow cytometry | |
| CN107941773B (zh) | 一种基于荧光分子的内毒素的检测方法 | |
| CN108279222B (zh) | 一种双波长共振瑞利散射法测定壳聚糖含量的方法 | |
| CN113533267B (zh) | 一种基于FITC的细胞微环境pH测定方法及其在破骨细胞封闭区中的应用 | |
| Karn et al. | Metal-Responsive Fluorophore and Amikacin-Conjugated Heparin for Bacterial Cell Imaging and Antibacterial Applications | |
| McKinnon et al. | Influence of uronic acids on the spontaneous precipitation of calcium L-(+)-tartrate in a model wine solution | |
| CN104459128A (zh) | 基于低噪声激发式荧光标记的沙门氏菌免疫层析试纸条 | |
| Uthicke et al. | Fluorescent lectin assay to quantify particulate marine polysaccharides on 96‐well filtration plates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180621 |
|
| EEER | Examination request |
Effective date: 20180621 |